Evidence map›Paper›PMID 34830401›Full record

ArticleInternational journal of molecular sciences2021

Antiseptic 9-Meric Peptide with Potency against Carbapenem-Resistant

Manigandan Krishnan, Joonhyeok Choi, Ahjin Jang, Young Kyung Yoon, Yangmee Kim

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Treatment of infections caused by carbapenem-resistantFrontiers in cellular and infection microbiology · 2024
    Review
  5. Protective Effects of Rhamnetin in Carbapenem-ResistantInternational journal of molecular sciences · 2023
    Article
  6. Review
  7. Lights and Shadows of Sepsis Management: Challenges and Future Perspectives.International journal of molecular sciences · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Manigandan KrishnanDepartment of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea.
Joonhyeok ChoiDepartment of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea.
Ahjin JangDepartment of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea.
Young Kyung YoonDepartment of Internal Medicine, Division of Infectious Diseases, College of Medicine, Korea University Anam Hospital, Korea University, Seoul 02841, Korea.
Yangmee KimDepartment of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea.ORCID 0000-0001-6438-4718
Konkuk University · KRKorea University · KR

Funding

National Research Foundation of Korea 2020R1A2C2005338National Research Foundation of Korea 2021R1F1A1048538
6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Infective Agents, LocalBiofilmsCarbapenemsDrug Resistance, BacterialHumansMicrobial Sensitivity TestsPeptidesAnti-Infective Agents, LocalCarbapenemsPeptidesA. baumanniiantimicrobial peptidecarbapenem-resistancesepsis

Identifiers

PMID34830401
PMCPMC8621208
OpenAlexW3216595746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.